Berger S H, Jenh C H, Johnson L F, Berger F G
Mol Pharmacol. 1985 Nov;28(5):461-7.
Cytotoxicity to 5-fluoro-2'-deoxyuridine (FdUrd) derives from its conversion to 5-fluorodeoxyuridine-5'-monophosphate, which binds to and inhibits thymidylate synthase (TS) in the presence of the cofactor, 5,10-methylenetetrahydrofolate. We have selected FdUrd-resistant variants of the human cell line HEp-2 following adaptation to stepwise increases in drug concentration. In the initial selection, maximal drug resistance was associated with a 26-fold increase in the cellular level of TS. Greater TS overproduction (80-fold) was obtained by selection for FdUrd resistance in the presence of 10 microM folinic acid and 100 microM deoxyinosine. The latter agents were included to expand the folate pool to ensure adequate levels of cofactor during the selection process. Using cDNA plasmid pMTS-4, which is complementary to mouse TS mRNA, we show that TS overproduction in the HEp-2 variants is accompanied by a 100-fold increase in TS mRNA and a 100-fold amplification of the TS structural gene. Thus, TS overproduction and gene amplification is a mechanism of resistance to FdUrd in human cells.
对5-氟-2'-脱氧尿苷(FdUrd)的细胞毒性源于其转化为5-氟脱氧尿苷-5'-单磷酸,在辅因子5,10-亚甲基四氢叶酸存在的情况下,该物质会结合并抑制胸苷酸合成酶(TS)。在逐步增加药物浓度的适应过程后,我们选择了人细胞系HEp-2的FdUrd抗性变体。在最初的筛选中,最大耐药性与TS细胞水平增加26倍相关。通过在10 microM亚叶酸和100 microM脱氧肌苷存在的情况下选择FdUrd抗性,可获得更高的TS过量表达(80倍)。加入后两种试剂是为了扩大叶酸池,以确保在筛选过程中有足够水平的辅因子。使用与小鼠TS mRNA互补的cDNA质粒pMTS-4,我们发现HEp-2变体中TS的过量表达伴随着TS mRNA增加100倍以及TS结构基因扩增100倍。因此,TS过量表达和基因扩增是人类细胞对FdUrd产生抗性的一种机制。